Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-591-01.
Published February 1, 2023 · Recall initiated: January 5, 2023
Summary
FDA records drug Class II recall D-0170-2023, published February 1, 2023 and initiated January 5, 2023. Recalling firm: Ascend Laboratories, LLC; Status: Terminated; Reported quantity: 6,336 bottles; Lot: Lot #: 21142633, Exp 03/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification
What to do
Voluntary: Firm initiated · E-Mail
Get an email if METOPROLOL SUCCINATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METOPROLOL SUCCINATE
- Manufacturer
- Ascend Laboratories, LLC
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 21142633, Exp 03/31/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAscend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by:May 20, 2026
- FDAMetoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01;July 9, 2025
- FDAMetoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00;February 22, 2023
- FDAMetoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by:February 1, 2023
- FDAMetoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 500 Tablets per bottle, Manufactured by:February 1, 2023
- FDAAllopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham,February 1, 2023
Questions about this recall
Was Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-591-01. recalled?
Yes. FDA published recall D-0170-2023 on February 1, 2023. Reported hazard: Failed Dissolution Specification
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METOPROLOL SUCCINATE.